Calin Point Lab Ltd. – Ethica Invest

999.00

Introduction :

Caplin Point is a fast growing, fully integrated Pharmaceutical company with a dominant presence in Latin
America, Francophone Africa and a growing presence in the Regulated markets such as USA and EU. The
company was established in 1990 to manufacture a range of ointments, creams and other external applications.
The Company was listed in 1994.

Caplin Point makes a variety of products in different forms for medical use in Generic & Branded Generic like
Tablets, Dry syrups – Bottles, Softgels, Capsules, Suppositories, Liquid syrups – Bottles, liquid injectables in
ampoules & vials, Lyophilized vials, Prefilled syringes (PFS),Emulsion injection in ampoules & vials, Topicals,
Sachets (Liquids & Powders) etc.

Note : Post payment Research Report will be emailed on registered id within 12 hours.

 

Add to Wishlist
Add to Wishlist

Description

Content of Report

  • Investment Rational
  • History
  • Business Model
  • R&D Capabilities
  • Profitability
  • Cash Flow & Capital Expenditure
  • News & Market Opportunities
  • Risk
  • Financial Summary

Shopping cart

0
image/svg+xml

No products in the cart.

Continue Shopping